about
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesisThe non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAsMiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31The HER2-encoded miR-4728-3p regulates ESR1 through a non-canonical internal seed interactionPAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.A promoter-level mammalian expression atlasPolymorphisms in DCDC2 and S100B associate with developmental dyslexia.HER2-encoded mir-4728 forms a receptor-independent circuit with miR-21-5p through the non-canonical poly(A) polymerase PAPD5.An integrated expression atlas of miRNAs and their promoters in human and mouse.Preparation of highly multiplexed small RNA sequencing libraries.Passenger strand loading in overexpression experiments using microRNA mimics.Frequent miRNA-convergent fusion gene events in breast cancer.Profiling of small RNA cargo of extracellular vesicles shed by Trypanosoma cruzi reveals a specific extracellular signature.Transcriptome analysis of controlled and therapy-resistant childhood asthma reveals distinct gene expression profiles.HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
P50
Q28256626-6D8F94FF-370F-4C27-AF0F-B939B1E0270DQ28258414-E40374A0-25DC-461D-8855-6253DA6F9C6DQ28305980-92C774B7-F589-46EC-9904-4C8CF34EC4B6Q33609935-87B9C745-E742-4905-9F8D-F2140A7DDFBDQ33609935-BE9B29B5-8034-44DF-830D-B676F4B4A1A1Q34025404-97007A4B-F7FB-45D1-88DE-8717231705A1Q34157268-68DB67F4-9B9C-44E5-A8D3-655062BC27F1Q34412203-FE0C6CAA-902E-4DA6-B9E1-A3F658DB6817Q35906065-2CF878C3-59AF-42C7-8CDE-DAB4F29F8D58Q37345945-E9A44F14-92AE-4CCB-8BBE-9DF0E8ED4026Q38614360-D917BD13-D27A-4CEC-A961-5F3147F8530EQ38627227-45EF2784-0946-4423-BDC4-9B41F8C0EBA3Q38859019-128DBD68-5472-4D60-9E73-78291DB27B5CQ42277454-8A573733-2CA2-4CD1-AF26-4B6A529EBDF1Q52957325-B08768D6-4F46-4D68-9C70-9F8DA5A8C6ABQ53549168-F142E59D-ED33-4853-B70A-2C501717901DQ64069811-F5D940ED-5438-483A-A028-98DCAE863279Q89749747-19945106-8B4D-424C-86F1-A14C10B98281
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helena Persson
@ast
Helena Persson
@en
Helena Persson
@es
Helena Persson
@nl
Helena Persson
@sl
type
label
Helena Persson
@ast
Helena Persson
@en
Helena Persson
@es
Helena Persson
@nl
Helena Persson
@sl
prefLabel
Helena Persson
@ast
Helena Persson
@en
Helena Persson
@es
Helena Persson
@nl
Helena Persson
@sl
P106
P21
P31
P496
0000-0002-5187-6446